Furthermore, FL118 performs those functions independent of p53 status (wild type, mutant, or null) in cells, and thus it can effectively control cancer with p53 function incapacity, in which most DNA damage drugs (if not all) show a marked lack of efficiency [7,11]. The gene discussed is TP53; the disease is cancer.